PD-L1 expression in malignant salivary gland tumors

BACKGROUND: Programmed death-1 ligand-1 (PD-L1) an important cancer biomarker that can suppress the immune system and its high expression is often reported to be related with increased tumor aggressiveness in some cancers. Here, we examined and evaluated PD-L1 expression in patients with malignant s...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Koji, Ferdous, Tarannum, Ueyama, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801834/
https://www.ncbi.nlm.nih.gov/pubmed/29409471
http://dx.doi.org/10.1186/s12885-018-4069-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801834/
https://www.ncbi.nlm.nih.gov/pubmed/29409471
http://dx.doi.org/10.1186/s12885-018-4069-3

Ejemplares similares